Clinical Laboratory Improvement Advisory Committee: Notice of Charter Amendment, 43779 [2015-18065]
Download as PDF
<![CDATA[
Federal Register / Vol. 80, No. 141 / Thursday, July 23, 2015 / Notices
contracts awarded annually at $100,000
or more, of which 65 percent or 11,375
contracts will be competitively
awarded. About 7 proposals will be
received for each contract award. Of the
total 79,625 (11,375 × 7) proposals
received, only 25 percent or 19,906
proposals are expected to include
uncompensated overtime hours. It is
estimated that offerors will take about
30 minutes to identify and support any
hours in excess of 40 hours per week
included in their proposal or
subcontractor’s proposal.
Number of Respondents: 19,906.
Responses Per Respondent: 1.
Total Annual Responses: 19,906.
Average Burden Hours Per Response:
.5.
Total Burden Hours: 9,953.
C. Public Comments
mstockstill on DSK4VPTVN1PROD with NOTICES
Public comments are particularly
invited on: Whether this collection of
information is necessary for the proper
performance of functions of the Federal
Acquisition Regulation (FAR), and
whether it will have practical utility;
whether our estimate of the public
burden of this collection of information
is accurate, and based on valid
assumptions and methodology; ways to
enhance the quality, utility, and clarity
of the information to be collected; and
ways in which we can minimize the
burden of the collection of information
on those who are to respond, through
the use of appropriate technological
collection techniques or other forms of
information technology.
Obtaining Copies of Proposals:
Requesters may obtain a copy of the
information collection documents from
the General Services Administration,
Regulatory Secretariat Division (MVCB),
1800 F Street NW., Washington, DC
20405, telephone 202–501–4755. Please
cite OMB Control No. 9000–0152,
Service Contracting, in all
correspondence.
Dated: July 20, 2015.
Edward Loeb,
Acting Director, Federal Acquisition Policy
Division, Office of Governmentwide
Acquisition Policy, Office of Acquisition
Policy, Office of Governmentwide Policy.
[FR Doc. 2015–18077 Filed 7–22–15; 8:45 am]
BILLING CODE 6820–EP–P
VerDate Sep<11>2014
18:39 Jul 22, 2015
Jkt 235001
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
Clinical Laboratory Improvement
Advisory Committee: Notice of Charter
Amendment
This gives notice under the Federal
Advisory Committee Act (Pub. L. 92–
463) of October 6, 1972, that the Clinical
Laboratory Improvement Advisory
Committee, Centers for Disease Control
and Prevention (CDC), Department of
Health and Human Services (HHS), has
amended their charter to reduce the
number of annual meetings and to
change the designation of CDC, FDA
and CMS from voting to non-voting ex
officio members. The amended filing
date is July 9, 2015.
For information, contact Nancy
Anderson, Chief, Laboratory Practice
Standards Branch, Division of
Laboratory Programs, Standards, and
Services, Center for Surveillance,
Epidemiology and Laboratory Services,
Office of Public Health Scientific
Services, CDC, 1600 Clifton Road, NE.,
Mailstop F–11, Atlanta, Georgia 30329–
4018; telephone (404) 498–2741.
The Director, Management Analysis
and Services Office, has been delegated
the authority to sign Federal Register
notices pertaining to announcements of
meetings and other committee
management activities, for both the
Centers for Disease Control and
Prevention and the Agency for Toxic
Substances and Disease Registry.
Elaine L. Baker,
Director, Management Analysis and Services
Office, Centers for Disease Control and
Prevention.
[FR Doc. 2015–18065 Filed 7–22–15; 8:45 am]
BILLING CODE 4163–18–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
43779
portfolio review and the Pediatric mildTraumatic Injury Workgroup. There will
be 15 minutes allotted for public
comments at the end of the open
session.
On the second day, the BSC, NCIPC
will meet to conduct a Secondary Peer
Review of extramural research grant
applications received in response to
four (4) Funding Opportunity
Announcements (FOAs): PHS 2014002
Omnibus Solicitation of the NIH, CDC,
FDA and ACF for Small Business
Innovation Research Grant Applications
(Parent SBIR {R42/R44}); CE15–003,
Evaluating Structural, Economic,
Environmental, or Policy Primary
Prevention Strategies for Intimate
Partner Violence and Sexual Violence;
CE15–004, Evaluating Innovative and
Promising Strategies to Prevent Suicide
among Middle-Aged Men; and CE15–
005, Research to Evaluate the CDC
Heads Up Initiative in Youth Sports.
Applications will be assessed as they
relate to the Center’s mission and
programmatic balance.
Recommendations from the secondary
review will be voted upon and the
application will be forwarded to the
Center Director for consideration for
funding support.
Contact Person For More Information:
Arlene Greenspan, DrPH, MPH, PT,
Associate Director for Science, Acting
Designated Federal Officer, NCIPC,
CDC, 4770 Buford Highway NE.,
Mailstop F–63, Atlanta, GA 30341,
Telephone (770) 488–1279.
The Director, Management Analysis
and Services Office, has been delegated
the authority to sign Federal Register
notices pertaining to announcements of
meetings and other committee
management activities, for both the
Centers for Disease Control and
Prevention and the Agency for Toxic
Substances and Disease Registry.
Elaine L. Baker,
Director, Management Analysis and Services
Office Centers for Disease Control and
Prevention.
[FR Doc. 2015–18064 Filed 7–22–15; 8:45 am]
BILLING CODE 4163–18–P
Board of Scientific Counselors,
National Center for Injury Prevention
and Control, (BSC, NCIPC)
Correction: This notice was published
in the Federal Register on June 16,
2015, Volume 80, Number 115, Page
34435. The Matters For Discussion and
Contact Person For More Information
should read as follows:
Matters For Discussion: The BSC,
NCIPC will discuss, research strategies
needed to guide the Center’s focus,
updates on the current research
PO 00000
Frm 00075
Fmt 4703
Sfmt 4703
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Food and Drug Administration
[Docket No. FDA–2015–N–2523]
Intent To Review a Study Data
Reviewer’s Guide Template
AGENCY:
Food and Drug Administration,
HHS.
E:\FR\FM\23JYN1.SGM
23JYN1
]]>Agencies
[Federal Register Volume 80, Number 141 (Thursday, July 23, 2015)]
[Notices]
[Page 43779]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2015-18065]
=======================================================================
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention
Clinical Laboratory Improvement Advisory Committee: Notice of
Charter Amendment
This gives notice under the Federal Advisory Committee Act (Pub. L.
92-463) of October 6, 1972, that the Clinical Laboratory Improvement
Advisory Committee, Centers for Disease Control and Prevention (CDC),
Department of Health and Human Services (HHS), has amended their
charter to reduce the number of annual meetings and to change the
designation of CDC, FDA and CMS from voting to non-voting ex officio
members. The amended filing date is July 9, 2015.
For information, contact Nancy Anderson, Chief, Laboratory Practice
Standards Branch, Division of Laboratory Programs, Standards, and
Services, Center for Surveillance, Epidemiology and Laboratory
Services, Office of Public Health Scientific Services, CDC, 1600
Clifton Road, NE., Mailstop F-11, Atlanta, Georgia 30329-4018;
telephone (404) 498-2741.
The Director, Management Analysis and Services Office, has been
delegated the authority to sign Federal Register notices pertaining to
announcements of meetings and other committee management activities,
for both the Centers for Disease Control and Prevention and the Agency
for Toxic Substances and Disease Registry.
Elaine L. Baker,
Director, Management Analysis and Services Office, Centers for Disease
Control and Prevention.
[FR Doc. 2015-18065 Filed 7-22-15; 8:45 am]
BILLING CODE 4163-18-P
